ArticleOncoimmunology2020

ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer.

Wenda Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.